Clinical Trial

Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

Study acronym: Bile-bar
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).
Trial Details
NCT Number NCT06925997
Lead Sponsor Hvidovre University Hospital
Conditions Bariatric Surgery Candidate, Bile Acid, Elevated Serum, Glucose Metabolism Disorders
Enrollment 18 participants
Start Date 2024-05-02
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-13